BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24575585)

  • 21. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.
    Reddy SK; Steel JL; Chen HW; DeMateo DJ; Cardinal J; Behari J; Humar A; Marsh JW; Geller DA; Tsung A
    Hepatology; 2012 Jun; 55(6):1809-19. PubMed ID: 22183968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease.
    Ong JP; Younossi ZM
    Clin Liver Dis; 2005 Nov; 9(4):617-34, vi. PubMed ID: 16207567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatocellular carcinoma without cirrhosis in a patient with nonalcoholic steatohepatitis].
    Bencheqroun R; Duvoux C; Luciani A; Zafrani ES; Dhumeaux D
    Gastroenterol Clin Biol; 2004 May; 28(5):497-9. PubMed ID: 15243330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgically treated cases of mixed hepatocellular carcinoma and cholangiocarcinoma.
    Uenishi T; Hirohashi K; Shuto T; Tsukamoto T; Yamamoto T; Kubo S; Tanaka H; Kinoshita H
    Hepatogastroenterology; 2002; 49(46):1083-6. PubMed ID: 12143207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.
    Brunt EM; Janney CG; Di Bisceglie AM; Neuschwander-Tetri BA; Bacon BR
    Am J Gastroenterol; 1999 Sep; 94(9):2467-74. PubMed ID: 10484010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity and hepatocellular carcinoma.
    Caldwell SH; Crespo DM; Kang HS; Al-Osaimi AM
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S97-103. PubMed ID: 15508109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
    Ascha MS; Hanouneh IA; Lopez R; Tamimi TA; Feldstein AF; Zein NN
    Hepatology; 2010 Jun; 51(6):1972-8. PubMed ID: 20209604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of massive hepatocellular carcinoma producing various imaging patterns after long-term follow-up].
    Wada A; Hama N; Tomimaru Y; Wada H; Akita H; Kawamoto K; Kobayashi S; Eguchi H; Doki Y; Mori M; Nagano H
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1783-5. PubMed ID: 24393921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Two cases of patients with hepatocellular carcinoma (HCC) that developed in cryptogenic cirrhosis suggestive of nonalcoholic steatohepatitis (NASH) as background liver disease after clinical courses of 26 years].
    Tsutsumi K; Nakayama H; Sakai Y; Kojima Y; Dairaku N; Ojima T; Kusano M; Ikeya S; Sugai Y; Hiwatashi N
    Nihon Shokakibyo Gakkai Zasshi; 2007 May; 104(5):690-7. PubMed ID: 17485950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history?
    Cotrim HP; ParanĂ¡ R; Braga E; Lyra L
    Am J Gastroenterol; 2000 Oct; 95(10):3018-9. PubMed ID: 11051414
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatocellular carcinoma in nonalcoholic fatty liver cirrhosis and alcoholic cirrhosis: risk factor analysis in liver transplant recipients.
    Jain D; Nayak NC; Saigal S
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):840-8. PubMed ID: 22495397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis.
    Salomao M; Remotti H; Vaughan R; Siegel AB; Lefkowitch JH; Moreira RK
    Hum Pathol; 2012 May; 43(5):737-46. PubMed ID: 22018903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A two-step right hepatic lobectomy with portal vein ligation for large hepatocellular carcinoma: rapid induction of left-lobe regeneration and clinicopathologic correlation.
    Ding X; Carrasco-Avino G; Thung SN; Roayaie S
    Semin Liver Dis; 2013 Aug; 33(3):293-7. PubMed ID: 23943109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis.
    Kawada N; Imanaka K; Kawaguchi T; Tamai C; Ishihara R; Matsunaga T; Gotoh K; Yamada T; Tomita Y
    J Gastroenterol; 2009; 44(12):1190-4. PubMed ID: 19672551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic steatohepatitis.
    Jansen PL
    Neth J Med; 2004; 62(7):217-24. PubMed ID: 15554595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient with hepatitis B and alcoholic liver disease before and after liver transplantation.
    Ward SC; Chang CY; Peng L; Liu LU
    Semin Liver Dis; 2009 May; 29(2):233-7. PubMed ID: 19387922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Ohata K; Hamasaki K; Toriyama K; Matsumoto K; Saeki A; Yanagi K; Abiru S; Nakagawa Y; Shigeno M; Miyazoe S; Ichikawa T; Ishikawa H; Nakao K; Eguchi K
    Cancer; 2003 Jun; 97(12):3036-43. PubMed ID: 12784339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The epidemiology of nonalcoholic fatty liver disease in adults.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.